Stephen Newman
Neurology · Plainview, NYNPI 1578549101
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $397,017 of the $489,330 with a category attached, or 81.1%. 25 manufacturers reported payments, led by Novartis at 31.1% of the total. Reporting peaked in 2019 at $241,762 and has fallen 100.0% since, to $15 in 2025. Among neurology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 531 payments — averaging $921.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$152K
- Biogen$126K
- Sanofi$91K
- EMD Serono, Inc.$61K
- Bristol Myers Squibb$24K
- Genentech USA, Inc.$23K
- plus $13K from 19 others
Across 45 payments — averaging $4429.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Adamas Pharmaceuticals, Inc.$67K
- Biogen$66K
- Novartis$31K
- Genentech, Inc.$30K
- Roche Products Limited$3K
- Mallinckrodt Hospital Products Inc.$2K
- plus $372 from 1 others
What the payments were for
- Consulting fees$50,43610%
- Speaking & faculty fees$397,01781%
- Travel & lodging$27,3876%
- Food & beverage$14,3523%
- Education$1390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 140 | $152,009 |
| Biogen | 120 | $125,645 |
| Sanofi | 60 | $91,259 |
| EMD Serono, Inc. | 66 | $60,578 |
| Bristol Myers Squibb | 26 | $23,530 |
| Genentech USA, Inc. | 28 | $23,157 |
| Novartis Pharma AG | 4 | $7,309 |
| E.r. Squibb & Sons, L.L.C. | 2 | $3,100 |
| Johnson & Johnson | 3 | $1,130 |
| AbbVie(2 entities) | 50 | $622 |
| AstraZeneca | 8 | $277 |
| Greenwich Biosciences, Inc. | 1 | $191 |
| Avanir Pharmaceuticals, Inc. | 5 | $116 |
| Teva Pharmaceuticals USA, Inc. | 1 | $109 |
| Genentech, Inc. | 3 | $55 |
| Pfizer | 2 | $52 |
| Sanofi-aventis U.S. LLC | 3 | $42 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| MDD US Operations, LLC | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Medtronic | 1 | $15 |
| Bayer | 1 | $15 |
| Abbott | 1 | $15 |
| Flowonix Medical Incorporated | 1 | $13 |
| Boston Scientific | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$489,330 in reported general payments places this provider in the 95th percentile of 1,623 neurology providers in New York.
Other neurology in Plainview
- Ira TurnerPlainview$597K
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
- Jennifer McVigeAmherst$982K
- Warren SpinnerPort Jefferson Station$791K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.